Abstract: A modular toilet is disclosed comprising a toilet shell and a hydraulic core. The hydraulic core module is a separate unit from the toilet shell module and may be non-symmetrical with the internal and external form of the shell. The core module comprises a toilet bowl connected to a siphon drain comprising a weir. The drain may be a vertical loop drain. The toilet shell and the hydraulic core may comprise mutual sealing surfaces. The drain may comprise openings for connection to a toilet ventilation system.

Abstract: The tandem differential mobility spectrometer (DMS)-ion modulator instrument provides improved resolution relative to traditional DMS for molecules with larger masses. The instrument includes an ion-bunching electrode with an AC field synchronized to the transit time of the ion flow which is positioned downstream of a DMS. The ion bunching electrode produces a mobility-dependent modulation of the ion current. The ratio of AC to DC current provides a measure of the mobility of a large ion, even if it has little differential mobility, thereby extending the useful range of mobility characterization of a DMS system. The instrument is more compact than a larger traditional ion mobility spectrometer and does not require high voltages or high frequencies. Modulation before DMS separation or between tandem DMS separations produces a variable range of analyte and reactant ion densities as well as spatially separating negative and positive ions to reduce ion recombination.

Abstract: The tandem differential mobility spectrometer (DMS)-ion modulator instrument provides improved resolution relative to traditional DMS for molecules with larger masses. The instrument includes an ion-bunching electrode with an AC field synchronized to the transit time of the ion flow which is positioned downstream of a DMS. The ion bunching electrode produces a mobility-dependent modulation of the ion current. The ratio of AC to DC current provides a measure of the mobility of a large ion, even if it has little differential mobility, thereby extending the useful range of mobility characterization of a DMS system. The instrument is more compact than a larger traditional ion mobility spectrometer and does not require high voltages or high frequencies. Modulation before DMS separation or between tandem DMS separations produces a variable range of analyte and reactant ion densities as well as spatially separating negative and positive ions to reduce ion recombination.

Abstract: A thin scale apparatus for measuring body weight includes 5 or more force sensors within a total thickness of between 0.4 inches and 0.004 inches measured between a bottom surface and a top surface of the thin scale apparatus. The thin scale is designed to be thin enough to be non-intrusive or not recognized by a user. A weight of a toilet user may be determined as a combination of additive force of force sensors in a thin scale and force sensor associated with a toilet seat of a toilet. The force sensors may be positioned in one or more cavities on a bottom side of a substrate material of the thin scale or be embedded within a substrate material. Embodiments of a standalone thin scale and a thin scale with a toilet are disclosed.

Abstract: A toilet is disclosed which, in general, includes a toilet bowl and a housing. The toilet bowl includes multiple apertures and a blower, wherein the blower is fluidly connected to one or more of the apertures. The housing is fluidly connected to the blower. The housing includes a gas permeable substrate and a gas chemical sensor. The gas permeable substrate comprises a first side, a second side, intercalated sorbent media, and a rapid desorption heater.

Abstract: We disclose a method of tagging a variety of pharmaceutical or nutritional products in which well-studied chemicals may be added to the products in unique ratios. The identities of the chemicals and their relative ratios comprise unique taggants. The taggants may identify which of multiple distinct categories the product falls within. The method includes the step of systematically varying the relative concentrations of the chemicals resulting in multiple ratios of the chemicals. The plurality of ratios of a defined set of chemicals may be collected to form a library of taggants associated with specified items or categories. As the number of chemicals added per product increases, the library supports more categories and the system is less likely to produce a false positive. The method may result in a series of taggants for each item which is single fault tolerant or double fault tolerant.

Abstract: We disclose a tag for tracking and identifying pharmaceutical and nutritional products. The tag includes a paramagnetic microparticle which is connected to at least one unique and detectable chemical. The chemical may be coated on the paramagnetic microparticle or connected through functional groups. The tags may be too large to be taken into the bloodstream and therefore remain in the user's gastrointestinal tract. The tags may be fully or partially isolated from feces for analysis. The tags are attracted to an external electromagnetic force but are not magnetically attracted to each other. Consequently, the tags are safe to ingest. The tags may vary in volume or mass so as to be separable according to mass. The tags may be non-spherical in shape thus increasing the surface area to volume ratio and increasing the amount of chemical which may be attached as a taggant.

Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition has decayed in response to environmental conditions and time. The taggants may decay in response to environmental conditions which cause drugs to lose their efficacy. The decay may occur due to improper storage or excursions into certain environmental conditions. These environmental conditions may include light, temperature, moisture, oxidation, and age. By including taggants that have different decay characteristics, the environmental condition that caused the decay may be determined. The amount of time the drug composition was exposed to the environmental condition and the amount of effective drug remaining may also be determined. The disclosed method may reduce the need for a unique assay for each drug to assess decay and determine shelf life. The disclosed method may also be used as a quality control technique for pharmaceutical products.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, moisture, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: We disclose a method of tagging nutritional or drug compositions using chemical entities which are known to be safely consumed and which are detectable using known techniques, including near IR spectroscopy. The chemical entities used as tags may be detected in easily obtainable biological samples, including urine and feces. The biological sample may be deposited into a medical toilet which may analyze the biological sample using an analytical device associated with the medical toilet. The tag may be identified and quantified to then identify and quantify the nutritional or drug composition the subject consumed along with the tag. This system may be used to track the source of a food or drug, confirm compliance to a prescribed diet or drug treatment, confirm drug consumption in clinical trials, identify the source of contaminated food, and identify the food substances used to produce food products.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: The present invention is directed to a toilet that includes a liquid level sensor on the surface of a flush jet fill tube. The liquid level sensor is a noncontact electrical impedance sensor that is an electrical capacitor. The capacitor may be used alone or with other volume sensors to detect volume of materials added to a toilet bowl. Some embodiments include a processor which records data and provides reports that may be clinically useful to assess the user's health status. The temporal nature of the liquid level sensor measurements is particularly useful because urination or defecation may be measured over time. Not only are total volumes detected but rates at which waste is deposited into the toilet during the entire excretion event are detected. These measurements are particularly useful in assessing certain health conditions.

Abstract: We disclose a drug tracking system and method of use which may be used to screen a subject's bodily waste in order to assess whether the subject has consumed a drug. The system includes a drug composition which is tagged with at least one artificial sweetener that may be detected in the subject's bodily waste. The subject may consume the tagged drug and a user may obtain a sample of the subject's bodily waste. The bodily waste sample may be analyzed to detect the artificial sweetener or its metabolite. In some embodiments, the result of the analysis of bodily waste may be entered into a database, compared to standards that comprises analyses of a plurality of drug tags, and the identity of the drug tag, and consequently the drug composition, determined.

Abstract: We disclose a device that both extracts and preconcentrates volatile analytes in preparation for separation by gas chromatography. The device includes a conduit that may include two, and sometimes three, separate sections that are connected end-to-end, but which may be separated prior to inserting into a gas chromatograph port. The inner surface of each section is coated with one or more sorbents, each with a different affinity for volatile analytes. The sorbents may be positioned along the sections of the column in order of relative affinity for volatile analytes. The sections may be heated independently of each other to release the volatile analytes from the sorbents more quickly. This device reduces the time and the temperature required to achieve separation by gas chromatography. The device may be used to perform gas chromatography in ubiquitous environments such as the home or a mobile situation.

Abstract: We disclose a drug tracking system and method of use which may be used to screen a user's bodily waste and to collect information about the drugs the user has consumed. The system includes mixing or adhering a drug tag with a drug compound. The drug tag includes at least one nucleic acid or nucleic acid analog, the unique nucleotide sequence of which correlates to information about the drug. The unique sequence may correlate with a drug molecule, a drug class, a manufacturer, and/or a distributer. Each of these categories of information may be incorporated into the nucleotide sequence of a separate nucleic acid or nucleic acid analog molecules or combined in a single molecule. The sequence of the drug tag may be entered into a database which stores the drug information associated with each discrete nucleotide sequence.

Abstract: A two-piece toilet with a seam and a channel at an intersection of the two toilet pieces is disclosed. An LED strip and diffuser strip are used to fill in the channel and hide seam of the intersection of the two toilet pieces. The LED strip transmits light into the channel and the light is refracted off of the channel and through the diffuser strip on the back side of the LED strip. An exterior and interior of a toilet may be lighted by the LED strip.

Abstract: A quiet toilet apparatus disclosed. Microphones and circuitry are used to receive and detect one or more virtual point source locations and propagation directions of unwanted toilet noise. Speakers are used to create one or more synthesized wave fronts resulting in cancelation and reduction of unwanted toilet noise. The speakers, microphones and circuitry may be located within a toilet seat of a toilet or at a remote location. A user device or remote device may be connected to the noise reduction toilet apparatus for data recording, collection, reporting, and electronic noise filtering.

Abstract: We disclose a toilet system which analyzes solid waste to detect tags which were associated with pharmaceutical or nutritional products and excreted in the solid waste of a user. The toilet system may include a receptacle for receiving solid waste, a liquid dispenser for providing a liquid to assist in dispersing the solid waste, a solid waste dispersing system which may mix the solid waste with the liquid thereby homogenizing the solid waste, and an electromagnetic signature detector which may analyze the tags in the solid waste. The electromagnetic signature detector may include a selective binding surface which may bind tags present in the solid waste and which may be connected to a transducer which senses the presence of bound tags.

Abstract: The present invention is directed to a device that measures volatile organic compounds (VOCs) emitted by an individual's urine, feces or present in flatulence for use in assessing the individual's health. The device may be part of a toilet. The device includes a gas sensor that measures VOCs in the air within the toilet bowl after waste is deposited therein. The device includes a manifold that keeps air from the toilet bowl separate from water and waste in the toilet bowl until the gas sensor has collected readings. Then the manifold combines the air, water, and waste before depositing the material into the sewer system. The gas sensor may be connected to a processor that analyses the gas sensor readings, provides a report of the analyzed data, and transmits the data to a network. A healthcare provider may download the data from the network to assess the individual's health.